跳至主要内容
临床试验/JPRN-C000000001
JPRN-C000000001已完成未知

Concurrent Treatment of Osteoporosis for Prevention of Vertebral Fracture in Japan - Multi-center Randomized Trial with Arendoronate and alfa-calcidol - - Japanese Osteoporosis Intervention Trial (JOINT) -02

Japan Osteoporosis Society/ A-TOP consortium0 个研究点目标入组 2,164 人开始时间: 2005年7月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
2,164

研究概览

简要总结

The combination therapy was no more effective for overall vertebral fracture prevention. However, subgroup analysis has shown that it was more effective for fracture prevention in patients with severe vertebral deformity, multiple prevalent vertebral fractures, and for non-vertebral weight-bearing bone fracture prevention.

研究设计

研究类型
Interventional

入排标准

年龄范围
70years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • Bone disease other than osteoporosis, having contraindication in using drugs, disfunction of communication of the intention, deformation of vertebra, hyperthyroidism, hyperparathyroidism, abnormal heart function, abnormal hepatic function, abnormal kidney function, taken bisphosponate within previous 6 months

研究者

发起方
Japan Osteoporosis Society/ A-TOP consortium

相似试验